PALISADE BIO, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Palisade Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Palisade Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $106K, a 41.8% decline year-over-year.
  • Palisade Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $566K, a 20.8% decline year-over-year.
  • Palisade Bio, Inc. annual Nonoperating Income (Expense) for 2023 was $770K, a 47.3% decline from 2022.
  • Palisade Bio, Inc. annual Nonoperating Income (Expense) for 2022 was $1.46M, a 90.4% decline from 2021.
  • Palisade Bio, Inc. annual Nonoperating Income (Expense) for 2021 was $15.2M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $566K $106K -$76K -41.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $642K $131K -$85K -39.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $727K $146K -$43K -22.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $770K $183K +$55K +43% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $715K $182K -$240K -56.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $955K $216K -$1.01M -82.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $1.97M $189K +$506K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.46M $128K -$4.97M -97.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $6.43M $422K -$10.7M -96.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $17.1M $1.23M +$116K +10.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $17M -$317K +$1.76M +84.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $15.2M $5.1M +$502K +10.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $14.7M $11.1M +$11.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $3.61M $1.11M +$1.12M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.48M -$2.08M +$3.51M +62.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$1.03M $4.6M +$4.5M +4740% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$5.53M -$27K -$388K -107% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$5.14M -$10K -$491K -102% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$4.65M -$5.58M -$4.93M -749% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $280K $95K -$1.39M -93.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 $1.67M $361K +$109K +43% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.56M $481K -$914K -65.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.48M -$657K -$859K -425% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $3.33M $1.48M +$2.53M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $804K $252K -$2.2M -89.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $3.01M $1.4M +$1.83M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.18M $202K +$3.54M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$2.36M -$1.05M -$1.3M -509% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$1.06M $2.45M +$2.76M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.81M -$431K -$413K -2263% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$3.4M -$3.34M -$2.96M -796% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$438K $256K +$670K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$1.11M -$303K +$137K +31.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$1.24M -$18.2K +$435K +96% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.68M -$372K +$68K +15.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$1.75M -$414K +$448K +52% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 -$2.2M -$440K -$91.6K -26.3% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q2 2015 -$2.1M -$453K +$2.79M +86% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$4.89M -$440K +$302K +40.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$5.19M -$862K -$322K -59.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$4.87M -$348K +$2.7M +88.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$7.58M -$3.24M -$224K -7.43% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$7.35M -$742K -$43.8K -6.28% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$7.31M -$541K -$552K -4658% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 -$6.76M -$3.05M -$3.06M -53029% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$3.7M -$3.02M -$3.02M -43976% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$674K -$698K -$709K -6792% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $34.9K $11.9K +$6.23K +110% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $28.7K $5.77K -$5.7K -49.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $34.4K $6.87K -$13.3K -65.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $47.7K $10.4K -$424K -97.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $472K $5.64K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-10
Q3 2011 $11.5K +$18.1K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $20.1K +$776K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $435K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$6.59K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$756K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.